Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLRA1 | P23415 | 1/20 | 0.38 |
| ▸ | SLC6A9 | P48067 | 1/20 | 0.38 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.38 |
| ▸ | CPB2 | Q96IY4 | 2/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.32 |
| ▸ | EYA2 | O00167 | 1/20 | 0.32 |
| ▸ | APP | P05067 | 1/20 | 0.32 |
| ▸ | ACE | P12821 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.31 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | DRD1 | P21728 | 1/20 | 0.31 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.31 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.31 |
| ▸ | DRD3 | P35462 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL98566 | 0.89 | GLRA1 (0.47) | GLRA1SLC6A9OR51E2TDP1EYA2 | |
| SCHEMBL2819946 | 0.80 | TERT (0.31) | — | |
| SCHEMBL7872934 | 0.80 | — | — | |
| SCHEMBL28596943 | 0.79 | GLRA1 (0.43) | GLRA1SLC6A9OR51E2TDP1EYA2 | |
| SCHEMBL17633987 | 0.79 | — | — | |
| SCHEMBL27465344 | 0.78 | TSHR (0.38) | GLRA1SLC6A9OR51E2TDP1EYA2 | |
| SCHEMBL21955799 | 0.76 | GLRA1 (0.39) | GLRA1SLC6A9OR51E2TDP1EYA2 | |
| SCHEMBL10503057 | 0.76 | — | — | |
| SCHEMBL7594029 | 0.75 | PTGS1 (0.42) | GLRA1SLC6A9OR51E2CPB2 | |
| SCHEMBL28547740 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118785925-A | Marker precursors and radiotracers with three or more targeting vectors for use in diagnostic nuclear medicine therapies | 原子治疗有限公司 | 2024-10-15 | — | — | CN | claimed |
| CN-116710150-A | Radiolabelled ether dendrimer conjugates for PET imaging and radiation therapy | 阿什瓦塔治疗股份有限公司 | 2023-09-05 | — | — | CN | claimed |
| CN-116635408-A | Reactive conjugates | 德彪药业国际股份公司 | 2023-08-22 | — | — | CN | claimed |
| US-8575100-B2 | Tc and Re labeled radioactive glycosylated octreotide derivatives | MALLINCKRODT LLC (US) | 2013-11-05 | — | — | US | claimed |
| US-7589061-B2 | Tc and Re labeler radioactive glycosylated octreotide derivatives | MALLINCKRODT INC. (US) | 2009-09-15 | — | — | US | claimed |
| WO-2025125335-A1 | CYTOTOXIC OR RADIOPHARMACEUTICAL COMPOUND WITH SULFUR FLUORIDE EXCHANGE GROUP | RADIOVAXX GMBH (DE) | 2025-06-19 | — | — | WO | disclosed |
| WO-2025125621-A1 | CANCER-ASSOCIATED PROTEIN-TARGETED STRONG OR COVALENTLY BINDING PRECURSOR COMPOUNDS AND RADIOTRACERS | RADIOVAXX GMBH (DE) | 2025-06-19 | — | — | WO | disclosed |
| CN-119053344-A | Dendrimer compositions for targeted delivery of therapeutic agents to neurons | 约翰霍普金斯大学 | 2024-11-29 | — | — | CN | disclosed |
| CN-118043482-A | Methods for predicting the response of a patient diagnosed with cancer to treatment and/or imaging with a CCK2-R targeting compound, and compounds for use in methods for selectively treating and/or imaging cancer | 保罗·谢勒学院 | 2024-05-14 | — | — | CN | disclosed |
| CN-117752825-A | Pharmaceutical composition containing tag-anti-human antibody Fab fragment complex | 安斯泰来制药株式会社 | 2024-03-26 | — | — | CN | disclosed |
| WO-2023222558-A1 | PRECURSOR AND THERANOSTIC RADIOTRACER WITH IMPROVED TUMOR RETENTION | ZOUNEK ALEXIS NIKOLAI (DE) | 2023-11-23 | — | — | WO | disclosed |
| CN-112839683-B | Pharmaceutical composition containing tag-anti-human antibody Fab fragment complex | 安斯泰来制药株式会社 | 2023-11-14 | — | — | CN | disclosed |
| WO-2003076469-A9 | ANTIBODIES DERIVED ROM ANTI ED-B L19 AND TARGETING TUMOR VASCULATURE | PHILOGEN SPA (IT) | 2005-09-29 | — | — | WO | disclosed |
| CN-1639195-A | Selective targeting of tumor vasculature using antibody molecules | PHILOGEN SRL (IT) | 2005-07-13 | — | — | CN | disclosed |
| EP-1548027-A1 | COMPOUND BINDING TO LEUKOCYTES AND MEDICINAL COMPOSITION CONTAINING THE COMPOUND IN LABELED STATE AS THE ACTIVE INGREDIENT | Nihon Medi-Physics Co., Ltd. (JP) | 2005-06-29 | — | — | EP | disclosed |
| US-20050074401-A1 | Selective targeting of tumor vasculature using radiolabelled antibody molecules | SCHERING AG (DE) | 2005-04-07 | — | — | US | disclosed |
| WO-2005023318-A1 | TARGETING OF TUMOR VASCULATURE USING RADIOLABELLED ANTIBODY L19 AGAINST FIBRONECTIN ED-B | PHILOGEN S.P.A (IT) | 2005-03-17 | — | — | WO | disclosed |
| EP-1514561-A1 | Targeting of tumor vasculature using radiolabelled antibody L19 against fibronectin ED-B | Philogen S.p.A. (IT) | 2005-03-16 | — | — | EP | disclosed |
| EP-1483297-A2 | ANTIBODIES DERIVED FROM ANTI ED-B L19 AND TARGETING TUMOR VASCULATURE | Philogen S.p.A. (IT) | 2004-12-08 | — | — | EP | disclosed |
| WO-2003076469-A2 | ANTIBODIES DERIVED ROM ANTI ED-B L19 AND TARGETING TUMOR VASCULATURE | PHILOGEN S.P.A. (IT) | 2003-09-18 | — | — | WO | disclosed |